← Back to Search

Imaging Device

High-Resolution PET Imaging for Head and Neck Cancer

N/A
Waitlist Available
Led By Eben Rosenthal, Ph.D
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient scheduled to undergo surgery for HNC
Biopsy-confirmed diagnosis of HNC
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights

Study Summary

This trial is to test a new PET camera's imaging quality on cancer patients and how it works in a clinical setting.

Who is the study for?
This trial is for adults 19 years or older with a biopsy-confirmed diagnosis of head and neck cancer (HNC), who are scheduled for surgery and a PET/CT scan. It's not suitable for those with conditions that could affect their participation as judged by the study leader.Check my eligibility
What is being tested?
The trial is testing a new PET camera system with 1-mm resolution to evaluate its image quality in diagnosing HNC, compared to conventional PET/CT systems, within a clinical setting.See study design
What are the potential side effects?
Since this trial involves imaging rather than medication or invasive treatment, there are no direct side effects from the intervention itself. However, standard risks associated with undergoing PET/CT scans apply.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for surgery for head and neck cancer.
Select...
My diagnosis of head and neck cancer was confirmed by a biopsy.
Select...
I am 19 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acquiring PET images of HNC patients with the 1 mm resolution PET imaging device.
Secondary outcome measures
Measure image quality of the 1 mm resolution PET imaging device

Trial Design

1Treatment groups
Experimental Treatment
Group I: Novel PET CameraExperimental Treatment1 Intervention
Patients already undergoing a PET/CT scan for HNC will afterwards undergo a PET scan with the proposed device, thus no additional radioactivity is needed as part of this study.

Find a Location

Who is running the clinical trial?

Emerson CollectiveUNKNOWN
2 Previous Clinical Trials
699 Total Patients Enrolled
Stanford UniversityLead Sponsor
2,387 Previous Clinical Trials
17,334,040 Total Patients Enrolled
Goldman Sachs FoundationUNKNOWN

Media Library

1-mm Resolution Clinical PET camera (Imaging Device) Clinical Trial Eligibility Overview. Trial Name: NCT04662554 — N/A
Head and Neck Cancers Research Study Groups: Novel PET Camera
Head and Neck Cancers Clinical Trial 2023: 1-mm Resolution Clinical PET camera Highlights & Side Effects. Trial Name: NCT04662554 — N/A
1-mm Resolution Clinical PET camera (Imaging Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04662554 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to join this study at the present time?

"As reported on clinicaltrials.gov, this medical trial is no longer recruiting participants. First posted in January 1st 2023 and last updated November 9th 2022, the study has concluded its recruitment process; however there are over 480 other studies that remain accepting patients at the moment."

Answered by AI
~7 spots leftby Jun 2025